Sven Gogov

Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial

Michael R. Migden, Alexander Guminski, Ralf Gutzmer et al. · The Lancet Oncology · 2015 · 419 citations

Surgical Oncology, Medicine, Metronomic Therapy +6

Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

Ronald B. Natale, Sumitra Thongprasert, F. Anthony Greco et al. · Journal of Clinical Oncology · 2011 · 296 citations

The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma

Reinhard Dummer, Alexander Guminski, Ralf Gutzmer et al. · Journal of the American Academy of Dermatology · 2016 · 159 citations · Full text

Low-Intensity Laser Therapy for Painful Symptoms of Diabetic Sensorimotor Polyneuropathy

Lorne Zinman, Eduardo Ng, Khin T. Nwe et al. · Diabetes Care · 2004 · 77 citations · Full text

Record-3: Phase II randomized trial comparing sequential first-line everolimus (EVE) and second-line sunitinib (SUN) versus first-line SUN and second-line EVE in patients with metastatic renal cell carcinoma (mRCC).

Robert J. Motzer, Carlos H. Barrios, Tae Min Kim et al. · Journal of Clinical Oncology · 2013 · 70 citations

Pharmacotherapy, Pre-clinical Pharmacology, Oncology +19